Department of Infectious Diseases, Renmin Hospital of Wuhan University, Wuhan, 430060, Hubei, China.
J Neuroimmune Pharmacol. 2020 Jun;15(2):196-208. doi: 10.1007/s11481-019-09890-x. Epub 2019 Nov 30.
Neuroinflammation is associated with the progression of multiple neurological diseases. Many studies show that SIRT2 involves in multiple inflammatory processes. While, the mechanisms remain unclear. The purpose of this study was to explore the effect of SIRT2 inhibitor AGK2 on inflammatory responses and MAPK signaling pathways in LPS activated microglia in vitro and in vivo. The effect of AGK2 on cell viability of BV2 microglial cells was detected by CCK-8 assay. The expression of inflammatory cytokine iNOS was analyzed by western blotting and immunofluorescence. The mRNA expressions of iNOS, TNF-α, and IL-1β were detected by real-time polymerase chain reaction (RT-PCR). The SIRT2, phospho-P38, P38, phospho-JNK, JNK, phospho-ERK, ERK, α-tubulin, and acetyl-α-tubulin were analyzed by western blotting respectively. The interaction between SIRT2 and MKP-1 was measured by Co-immunoprecipitation (Co-IP) assay. Double immunofluorescent staining was performed to detect the expressions of CD11b and iNOS or SIRT2 in brain tissues. We found that AGK2 could suppress LPS-induced inflammatory cytokines (iNOS, TNF-α, and IL-1β) expression levels in BV2 microglial cells. Moreover, it could effectively reduce the expression of SIRT2 and increase the acetylation of α-tubulin in LPS activated BV2 microglial cells and LPS induced mice neuroinflammation. In addition, our results showed that AGK2 could reduce the increase of phosphorylation p38, JNK, and ERK after LPS challenge. Co-IP results showed that there was no direct interaction between MKP-1 and SIRT2. However, AGK2 by inhibition of SIRT2 could increase the expression of MKP-1. Furthermore, AGK2 could inhibit the activation of BV2 microglia and expression of iNOS and SIRT2 in LPS treated mice brain tissue. Taken together, our results suggested that AGK2 might alleviate lipopolysaccharide induced neuroinflammation through regulation of mitogen-activated protein kinase phosphatase-1. Graphical abstract.
神经炎症与多种神经退行性疾病的进展有关。许多研究表明 SIRT2 参与多种炎症过程。然而,其机制尚不清楚。本研究旨在探讨 SIRT2 抑制剂 AGK2 在 LPS 激活的体外和体内小胶质细胞炎症反应及 MAPK 信号通路中的作用。通过 CCK-8 法检测 AGK2 对 BV2 小胶质细胞活力的影响。Western blot 和免疫荧光法分析炎症细胞因子 iNOS 的表达。实时聚合酶链反应(RT-PCR)检测 iNOS、TNF-α 和 IL-1β 的 mRNA 表达。Western blot 分别分析 SIRT2、磷酸化 P38、P38、磷酸化 JNK、JNK、磷酸化 ERK、ERK、α-微管蛋白和乙酰化α-微管蛋白。通过 Co-免疫沉淀(Co-IP)测定 SIRT2 与 MKP-1 的相互作用。双免疫荧光染色检测脑组织中 CD11b 和 iNOS 或 SIRT2 的表达。我们发现 AGK2 可抑制 LPS 诱导的 BV2 小胶质细胞中炎症细胞因子(iNOS、TNF-α 和 IL-1β)的表达水平。此外,它可以有效降低 LPS 激活的 BV2 小胶质细胞和 LPS 诱导的小鼠神经炎症中 SIRT2 的表达,并增加α-微管蛋白的乙酰化。此外,我们的结果表明,AGK2 可以减少 LPS 刺激后磷酸化 p38、JNK 和 ERK 的增加。Co-IP 结果表明 MKP-1 和 SIRT2 之间没有直接相互作用。然而,AGK2 通过抑制 SIRT2 可以增加 MKP-1 的表达。此外,AGK2 可抑制 LPS 处理小鼠脑组织中 BV2 小胶质细胞的激活和 iNOS 和 SIRT2 的表达。综上所述,我们的研究结果表明,AGK2 可能通过调节丝裂原活化蛋白激酶磷酸酶-1 来减轻脂多糖诱导的神经炎症。